Bharat Parenterals Equity Shares Admitted to Trading on NSE

Bharat Parenterals Limited has announced that its equity shares have been admitted to dealings on the Capital Market Segment of the National Stock Exchange of India Limited (NSE). This follows permission granted by NSE, effective August 17, 2026. The company's shares will now be traded on NSE under the 'Permitted to Trade' category, in addition to their existing listing on BSE Limited. The NSE circular, dated August 14, 2026, details the admission and trading regulations, including designated security codes and market lot sizes. This dual listing is expected to enhance liquidity and market accessibility for the company's shares.